DiaMedica Therapeutics to Present Research at the National Kidney Foundation’s 2021 Spring …,

(Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, …, (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, …, Read More

Scroll to Top